Rhodium(III)-Catalyzed C–H Bond Activation and [3+3] Spirocyclization of Benzoxazines with CF 3 -Imidoyl Sulfoxonium Ylides toward Trifluoromethyl-Substituted Spiroheterocyclic Compounds
The Journal of Organic Chemistry · 17.04.2026 · 91 (15) · 5388-5401
DOI: 10.1021/acs.joc.6c00334 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Organic Chemistry, online erschienen am 03.04.2026. Verfasst von Qihua Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China.
ORCID-Profile: Zhengkai Chen
Förderung
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Chen, Q., Cui, Z., & Chen, Z. (2026). Rhodium(III)-Catalyzed C–H Bond Activation and [3+3] Spirocyclization of Benzoxazines with CF 3 -Imidoyl Sulfoxonium Ylides toward Trifluoromethyl-Substituted Spiroheterocyclic Compounds. The Journal of Organic Chemistry, 91(15), 5388-5401. https://doi.org/10.1021/acs.joc.6c00334
Vancouver
Chen Q, Cui Z, Chen Z. Rhodium(III)-Catalyzed C–H Bond Activation and [3+3] Spirocyclization of Benzoxazines with CF 3 -Imidoyl Sulfoxonium Ylides toward Trifluoromethyl-Substituted Spiroheterocyclic Compounds. The Journal of Organic Chemistry. 2026;91(15):5388-5401. doi:10.1021/acs.joc.6c00334
BibTeX
@article{Chen2026,
author = {Chen, Qihua and Cui, Zhenye and Chen, Zhengkai},
title = {Rhodium(III)-Catalyzed C–H Bond Activation and [3+3] Spirocyclization of Benzoxazines with CF 3 -Imidoyl Sulfoxonium Ylides toward Trifluoromethyl-Substituted Spiroheterocyclic Compounds},
journal = {The Journal of Organic Chemistry},
year = {2026},
volume = {91},
number = {15},
pages = {5388--5401},
doi = {10.1021/acs.joc.6c00334}
}
EUVIMED